(Q36338885)

13 August 2017

1 reference

title

The population effectiveness of highly active antiretroviral therapy: are good drugs good enough? (English)

1 reference

13 August 2017

main subject

anti-retroviral agent

0 references

author name string

Thomas P Giordano

series ordinal

1

1 reference

13 August 2017

Maria E Suarez-Almazor

series ordinal

2

1 reference

13 August 2017

Richard M Grimes

series ordinal

3

1 reference

13 August 2017

publication date

1 November 2005

1 reference

13 August 2017

published in

Current HIV/AIDS reports

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

177-183

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-005-0013-7

13 August 2017

exact match

0 references

cites work

Trends in AIDS incidence and survival among racial/ethnic minority men who have sex with men, United States, 1990-1999.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0013-7

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0013-7

Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0013-7

Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0013-7

Provider assessment of adherence to HIV antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-005-0013-7

Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.

21 January 2018

1 reference

12 December 2020

Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization

1 reference

12 December 2020

Potential barriers to seeking human immunodeficiency virus testing among adults in the United States: data from the 1998 National Health Interview Survey

1 reference

12 December 2020

Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active?

1 reference

12 December 2020

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

1 reference

12 December 2020

The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals

1 reference

12 December 2020

Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study.

1 reference

12 December 2020

Assessment of readiness to initiate antiretroviral therapy.

1 reference

12 December 2020

Following-up for HIV test results: what limits return in an STD clinic population?

1 reference

12 December 2020

Medically eligible women who do not use HAART: the importance of abuse, drug use, and race

1 reference

12 December 2020

Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003.

1 reference

12 December 2020

Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings

1 reference

12 December 2020

Late versus early testing of HIV--16 Sites, United States, 2000-2003.

1 reference

12 December 2020

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

1 reference

12 December 2020

Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts

1 reference

12 December 2020

Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy

1 reference

12 December 2020

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

12 December 2020

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users

1 reference

12 December 2020

A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women

1 reference

12 December 2020

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

1 reference

12 December 2020

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

1 reference

12 December 2020

Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance

1 reference

12 December 2020

Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data

1 reference

12 December 2020

Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus

1 reference

12 December 2020

Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome

1 reference

12 December 2020

Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure

1 reference

12 December 2020

Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic

1 reference

12 December 2020

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

1 reference

12 December 2020

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy

1 reference

12 December 2020

Distinguishing efficacy, individual effectiveness and population effectiveness of therapies

1 reference

12 December 2020

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

1 reference

12 December 2020

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

1 reference

12 December 2020

Number of persons tested for HIV--United States, 2002.

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Detection of acute infections during HIV testing in North Carolina.

1 reference

12 December 2020

Think HIV: why physicians should lower their threshold for HIV testing.

1 reference

12 December 2020

Healthcare use by varied highly active antiretroviral therapy (HAART) strata: HAART use, discontinuation, and naivety

1 reference

12 December 2020

Recommendations for incorporating human immunodeficiency virus (HIV) prevention into the medical care of persons living with HIV.

1 reference

12 December 2020

Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world

1 reference

12 December 2020

Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care

1 reference

12 December 2020

Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?

1 reference

12 December 2020

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy

1 reference

12 December 2020

An overview of interventions to improve compliance with appointment keeping for medical services

1 reference

12 December 2020

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

1 reference

12 December 2020

10.1007/S11904-005-0013-7

Identifiers

DOI

1 reference

13 August 2017

1 reference